Similar Articles
Peripheral and Cortical Silent Period in Parkinson's Disease and Effects of L-DOPA
Sibel ÖZKAYNAK, Berrin AKTEKİN, Korkut YALTKAYA
Issue: 1998, Volume 4 - Issue 3-4
0
96
Movement Related Cortical Potentials and L-DOPA in Parkinson 's Disease
Sibel ÖZKAYNAK, Berrin AKTEKİN, Korkut YALTKAYA
Issue: 1998, Volume 4 - Issue 3-4
0
94
H-Reflex Recovery Ratios for Alfa Motor Neuron Excitability in Parkinson's Disease
Ayhan ÖZTÜRK, Hilmi UYSAL
Issue: 1998, Volume 4 - Issue 3-4
0
78
New Developments in Parkinson's Disease Management
M. Cenk AKBOSTANCI
Issue: 1998, Volume 4 - Issue 1-2
0
76
P300 and P300 Topographic Mapping in Parkinson's Disease
Raif ÇAKMUR, Fethi İDİMAN, Barış BAKLAN, Birsen KESKİN, Görsev YENER, Şakir FADILOĞLU
Issue: 1995, Volume 1 - Issue 4
0
88
THE THERAPY OF PARKINSON'S DISEASE: UNDERSTANDING AND MANAGING THE PROBLEMS
Bülent ELİBOL
Issue: 1995, Volume 1 - Issue 1
0
97
COVID-19-associated Leukoencephalopathy Involving the Splenium of the Corpus Callosum
Özlem Kayım Yıldız, Bülent Yıldız, Mürşit Hasbek, Gülsüm Aslı Tatlı, Murtaza Öz
DOI: 10.4274/tnd.2021.38445
Issue: 2021, Volume 27 - Supplement 1
0
117
Epigenetic analysis of heat shock activator complex in the peripheral blood of Parkinson's disease patients and its clinical significance
Yagmur İnalkac Gemici, Irem Tasci, Muhammed Dundar, Nazmi Ozgen, Nefsun Danis, Harika Gozde Gozukara, Ahmet Koc
DOI: 10.55697/tnd.2024.110
Issue: 2024, Volume 30 - Issue 2
127
57
Impact of a 12-week structured exercise program on motor function and exosomal alpha-synuclein levels in Parkinson's disease: A prospective analysis
Nihat Mustafayev, Abdulkadir Tunç, Birsen Elibol, Kamer Unal Eren, Sule Terzioglu-Usak
DOI: 10.55697/tnd.2024.8
Issue: 2024, Volume 30 - Issue 2
330
107